Canaccord Genuity Maintains Buy on Doximity, Raises Price Target to $40

Benzinga · 2d ago
Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:DOCS) with a Buy and raises the price target from $36 to $40.